Activity Description:

Total hip and knee replacements are among the most commonly performed surgeries worldwide, providing relief for millions of patients suffering from debilitating joint pain, arthritis, and other musculoskeletal conditions. As the demand for these procedures continues to rise, the field of orthopedics is undergoing rapid transformation. Surgeons are increasingly adopting innovative technologies to enhance the precision, efficiency, and outcomes of joint replacement surgeries. This session will offer valuable insights into how embracing innovation can lead to better outcomes, enhanced patient experiences, and a brighter future for those undergoing joint replacement procedures. This activity will provide attendees with the knowledge needed to stay at the forefront of technological advancements in total joint replacement surgery and how these innovations can directly benefit their patients.

Target Audience: 

This course is designed for hospitalists, nurse practitioners, physician assistants, advance practice nurses, registered nurses, allied health professionals, physicians and residents.

Learning Objectives:

• Explain how robotic-assisted surgery, computer navigation, and advanced imaging technologies enhance surgical precision in total joint replacement, leading to improved patient outcomes.
• Asses how new technologies can allow patients' progress to be monitored remotely, contribute to better surgical outcomes and faster recovery times for patients.
• Identify and describe the latest advances in augmented reality in joint replacement, and the role of AR/AI in improving patient monitoring, recovery, and long-term results post-surgery.

01.15.25 PSL Grand Rounds Flyer.pdf

Moderator:

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.